AC-55541

PAR agonist

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

AC-55541 is a small-molecule protease-activated receptor agonist used in experimental studies.

Regarding SARS-CoV-2, our AIM tool found the data that AC-55541 could help against SARS-CoV-2 by modulating its interactors.

Link	Tested on	Impact factor	Notes	Publication date
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Small molecule	in silico	42.78		Apr/30/2020

Link	Publication date
Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach.	Jul/15/2021